alcohol glp 1 Can semaglutide help reduce craving and consumption in adults with alcohol use disorder?, A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence. , π Read the What Alcohol Actually Does to
Description
(2025, November 20)
Funding No funding was received
In the SURMOUNT-1 clinical trial, participants on the highest dose of Mounjaro (15 mg) lost an average of 22.5% of their body weight over 72 weeks 1
Second, users of GLP-1RAs are more likely to be overweight or obese, and adiposity itself is a well-established risk factor for ED
